SB-267268, a nonpeptidic antagonist of alphavbeta3 and alphavbeta5 integrins, reduces angiogenesis and VEGF expression in a mouse model of retinopathy of prematurity

Jennifer Wilkinson-Berka; Daria Jones; George Taylor; Kassie Ann Jaworski; Darren J Kelly; Steve B Ludbrook; Robert N Willette; Sanjay Kumar; Richard E Gilbert

SB-267268, a nonpeptidic antagonist of alphavbeta3 and alphavbeta5 integrins, reduces angiogenesis and VEGF expression in a mouse model of retinopathy of prematurity

Jennifer Wilkinson-Berka
, Daria Jones
, George Taylor
, Kassie Ann Jaworski
, Darren J Kelly
, Steve B Ludbrook
, Robert N Willette
, Sanjay Kumar
, Richard E Gilbert

Immunology Alfred Hospital

Research output: Contribution to journal › Article › Research › peer-review

Original language	English
Pages (from-to)	1600 - 1605
Number of pages	6
Journal	Investigative Ophthalmology and Visual Science
Volume	47
Issue number	4
Publication status	Published - 2006

Cite this

Wilkinson-Berka, J., Jones, D., Taylor, G., Jaworski, K. A., Kelly, D. J., Ludbrook, S. B., Willette, R. N., Kumar, S., & Gilbert, R. E. (2006). SB-267268, a nonpeptidic antagonist of alphavbeta3 and alphavbeta5 integrins, reduces angiogenesis and VEGF expression in a mouse model of retinopathy of prematurity. Investigative Ophthalmology and Visual Science, 47(4), 1600 - 1605.

@article{01dbcaf3812344509d0bd634e0439c2a,

title = "SB-267268, a nonpeptidic antagonist of alphavbeta3 and alphavbeta5 integrins, reduces angiogenesis and VEGF expression in a mouse model of retinopathy of prematurity",

author = "Jennifer Wilkinson-Berka and Daria Jones and George Taylor and Jaworski, \{Kassie Ann\} and Kelly, \{Darren J\} and Ludbrook, \{Steve B\} and Willette, \{Robert N\} and Sanjay Kumar and Gilbert, \{Richard E\}",

year = "2006",

language = "English",

volume = "47",

pages = "1600 -- 1605",

journal = "Investigative Ophthalmology and Visual Science",

issn = "0146-0404",

publisher = "Association for Research in Vision and Ophthalmology (ARVO)",

number = "4",

}

Wilkinson-Berka, J, Jones, D, Taylor, G, Jaworski, KA, Kelly, DJ, Ludbrook, SB, Willette, RN, Kumar, S & Gilbert, RE 2006, 'SB-267268, a nonpeptidic antagonist of alphavbeta3 and alphavbeta5 integrins, reduces angiogenesis and VEGF expression in a mouse model of retinopathy of prematurity', Investigative Ophthalmology and Visual Science, vol. 47, no. 4, pp. 1600 - 1605.

SB-267268, a nonpeptidic antagonist of alphavbeta3 and alphavbeta5 integrins, reduces angiogenesis and VEGF expression in a mouse model of retinopathy of prematurity. / Wilkinson-Berka, Jennifer; Jones, Daria; Taylor, George et al.
In: Investigative Ophthalmology and Visual Science, Vol. 47, No. 4, 2006, p. 1600 - 1605.

Research output: Contribution to journal › Article › Research › peer-review

TY - JOUR

T1 - SB-267268, a nonpeptidic antagonist of alphavbeta3 and alphavbeta5 integrins, reduces angiogenesis and VEGF expression in a mouse model of retinopathy of prematurity

AU - Wilkinson-Berka, Jennifer

AU - Jones, Daria

AU - Taylor, George

AU - Jaworski, Kassie Ann

AU - Kelly, Darren J

AU - Ludbrook, Steve B

AU - Willette, Robert N

AU - Kumar, Sanjay

AU - Gilbert, Richard E

PY - 2006

Y1 - 2006

UR - http://www.scopus.com/record/display.url?eid=2-s2.0-33645988568&origin=inward&txGid=wpKO6atOD83PI4Fscozu943%3a32

M3 - Article

SN - 0146-0404

VL - 47

SP - 1600

EP - 1605

JO - Investigative Ophthalmology and Visual Science

JF - Investigative Ophthalmology and Visual Science

IS - 4

ER -

SB-267268, a nonpeptidic antagonist of alphavbeta3 and alphavbeta5 integrins, reduces angiogenesis and VEGF expression in a mouse model of retinopathy of prematurity

Other files and links

Cite this